Navigation Links
New Insights, Inroads Against Breast, Ovarian Cancers
Date:5/31/2009

urham, N.C. Still, "I doubt every treating oncologist will stop using this to follow treatment."

Another oncologist agreed. "This study suggests that early detection of metastatic cancer did not improve survival," said Dr. Claudine Isaacs, a medical oncologist with Georgetown's Lombardi Comprehensive Cancer Center in Washington, D.C. Unfortunately, the usefulness of CA125 in initial cervical cancer screening remains "questionable."

But there was good news at the meeting for women battling tough-to-treat breast cancers.

Two new studies found promising results with an entirely new class of drugs, called PARP inhibitors -- the first targeted therapy for so-called "triple-negative" breast cancer. Currently, the 15 percent of breast cancer patients who have this type of aggressive tumor have only the option of surgery and chemotherapy.

Breast cancers associated with the BRCA1 and BRCA 2 gene mutations (which heighten risk) are almost always triple negative, explained Dr. Joyce O'Shaughnessy, lead author of one of the studies and co-director of the Breast Cancer Research Program at Baylor-Charles A. Sammons Cancer Center in Dallas.

About 30 percent of women with triple negative cancer experience a recurrence and, once that happens, only survive a year or so.

In this phase II trial, half of the 120 women with this form of metastatic breast cancer were randomized to receive chemo alone, the other half to chemo plus the PARP inhibitor BSI-201.

Those receiving the combination therapy saw almost a doubling of their survival -- from 5.7 months with chemo alone to 9.2 months when BSI-201 was added in, as well as about a 60 percent reduction in the risk of dying from the disease. There were also no additional side effects as compared with standard chemo.

The second phase II PARP inhibitor trial involved 54 women with advance breast cancer who carried the BRCA1/2 mutations. In this trial, t
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. MedInsights, Inc. Selects Douglas Young as VP - Sales & Product Development
2. EMBASE Classic Makes Inroads into Pharmaceutical Industry
3. EMBASE Classic makes inroads into pharmaceutical industry
4. Small Health Plans Making Inroads in Florida Marketplace
5. Genetic Medicine Making Inroads Against Disease
6. Science Makes Inroads Against Prostate, Other Cancers
7. Experts Highlight Inroads to Preventing Cancer
8. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
9. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
10. Despite overeating, morbidly obese mice gain protection against diabetes
11. Alvarado Hospital Files Countersuit Against Blue Shield
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Insights, Inroads Against Breast, Ovarian Cancers
(Date:6/30/2015)... Minn. (PRWEB) , ... June 30, 2015 , ... The ... million in funding for 24 projects across the state. The projects improve community health ... range from $25,000 to $100,000 and many are renewable for a second year in ...
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, the premier provider of ... Mann, CPC, RCC, ROCC, Coding Documentation and Education Manager, was honored at the ... for her contribution to the RBMA Coding Subcommittee. , Ms. Mann served ...
(Date:6/30/2015)... Chicago, IL (PRWEB) , ... June 30, 2015 , ... ... to educate women on fertility preservation and deciding the right age to pursue egg ... child until after the age of 35 — a 150 percent increase since the ...
(Date:6/30/2015)... San Diego, California (PRWEB) , ... June 30, 2015 , ... ... Sullivan Solar Power today at a media event in San Diego. Speakers and clean ... San Diego School of medicine, Natalie Germuska of Kindred Hospital, and Daniel Sullivan, founder ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... today that they have been awarded the exclusive billing agreements with Jackson Radiology ... of billing services encompassing their proprietary suite of billing process software functionality called ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2Health News:ADVOCATE’s Debby Mann Honored With Special Recognition Award 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 2Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 3Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 4Health News:LIV Fertility Center Educating Women on the Critical Timing of Egg Freezing 5Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2
... has roped in Bayer HealthCare to market its recombinant ... //said in a statement Wednesday. ,The Bangalore-based ... 2007-08 after completing the registration trials and seeking the ... will be extended to other countries in the Asia-Pacific ...
... of the Center for Organic and Medicinal Chemistry F. ... Problems of Drug Dependence's 2006 Nathan B. Eddy Memorial ... addiction. ,Carroll has led RTI research focusing ... Among his many achievements, Carroll developed RTI-336 and JDTic, ...
... University researchers it was found that by appreciating how ... options can be developed to help patients suffering from ... causes of heart attack and stroke. The study, released ... a gene called heme oxygenase-1 (HO-1) markedly protects the ...
... study conducted by the researchers at the Mayo clinic it is ... particular type of heart failure.// ,The data was collected ... that there is a rise in the number of diastolic heart ... half of heart failure cases. The results of the study were ...
... particularly in terms of economic growth, could take a severe ... a UN report said here today. // ,The ... the likely impact of the epidemic over a 14-year period ... of HIV/AIDS, the country's economic growth over the next 10-15 ...
... has been highlighted again by the preliminary judgement yesterday ... ,Eight years ago Senator Henry, a medical ... regulate such clinics. Recently, Health Minister Mary Harney asked ... assisted human reproduction in Ireland. ,According to ...
Cached Medicine News:Health News:Bayer to Market Biocon Insulin in China 2Health News:Scientist Recognized for Drug Addiction Research 2Health News:Genes Identified To Protect Heart Muscles 2Health News:Diastolic Heart Failure on the Rise 2Health News:Regulation of Infertility Clinics Needed 2
(Date:6/30/2015)... -- Pulse Light Clinic in London,s ... as part of their ongoing research into the condition. They ... their Rosacea. The survey participants were aged between 20 and ... women. The results revealed some rather surprising statistics: ... attempt to visit their GP for Rosacea treatment. ...
(Date:6/30/2015)... , June 30, 2015 First Choice ... to the Astanza Duality and is the only clinic ... offering professional tattoo removal treatments. The practice has recently ... Removal brand to showcase their focus in the ... residents better results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... 2015  Avanir Pharmaceuticals, Inc. today announced top-line ... treatment with NUEDEXTA ® was associated with ... affect (PBA) in patients with traumatic brain injury ... characterized by sudden and uncontrollable outbursts of laughing ... brain injury. PRISM II is a phase IV ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Calif., Jan. 26, 2012  Cardica, Inc. (Nasdaq: CRDC ... its fiscal second quarter ended December 31, 2011, on Monday, ... host a conference call at 4:30 p.m. Eastern Time to ... company,s business. Conference Call Details ...
... LONDON, Jan. 26, 2012  The IP & Science ... with Brazil,s Institute for Applied Economic Research (IPEA). ... and Policies for Innovation, Regulation and Infrastructure (DISET) ... suite of products, supplying them with generic pharmaceutical ...
Cached Medicine Technology:Cardica to Announce Fiscal 2012 Second Quarter Financial Results on Monday, February 6, 2012 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Opportunities in the Generic Drug Landscape 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: